CT features of 42 masses in the bladder wall were characterized and subjected to analysis to find indicators of malignancy. A CT technique with thin slices and intravenous contrast medium was used. Multiple regression and multivariate analysis showed good ability of contrast-enhanced CT to discriminate between benign and malignant masses in the bladder wall. Protrusion of a mass into the perivesical fat had some importance in discriminating between malignant tumors with and without perivesical growth although the detection of perivesical growth was less certain.
BloomH. J. G.HendryW. F.WallaceD. M.SkeetR. G.: Treatment of T3 bladder cancer. Controlled trial of preoperative radiotherapy and radical cystectomy versus radical radiotherapy. Second report and review. Br. J. Urol.54 (1982), 136.
2.
BurgnerF. A.HamlinD. J.: Intravenous contrast enhancement in computed tomography of pelvic malignancies. RÖFO134 (1981), 656.
3.
CoxD. R.: The analysis of binary data. Methuen, London1970.
4.
DeanP. B.: Contrast media in body computed tomography. Experimental and theoretical background, present limitations and proposals for improved diagnostic efficacy. Invest. Radiol.15 (1980), 164.
5.
DeanP. B.KormanoM.: Intravenous bolus of 125I labeled meglumine diatrizoate. Early extravascular distribution. Acta Radiol. Diagnosis18 (1977), 293.
6.
FriedlandG. W.: Staging of genitourinary cancers. The role of diagnostic imaging. Cancer60 (1987), 450.
7.
GullinoP. M.: The internal milieu of tumors. In:Progress in experimental tumor research, p. 1. Karger, Basel1966.
8.
HamlinD. J.BurgenerF. A.BeechamJ. B.: CT of intramural endometrial carcinoma. Contrast enhancement is essential. AJR137 (1981), 551.
9.
HussainS.BelldegrunA.SeltzerS. E.RichieJ. P.GittesR. F.AbramsH. L.: Differentiation of malignant from benign adrenal masses. Predictive indices on computed tomography. AJR144 (1985), 61.
10.
KormanoM.DeanP. B.: Extravascular contrast material. The major component of contrast enhancement. Radiology121 (1976), 379.
11.
KormanoM.GoskeM. J.HamlinD. J.: Attenuation and contrast enhancement of gynecoloogic organs and tumors in CT. Eur. J. Radiol.1 (1981), 307.
12.
KormanoM.KiilholmaP.GrönroosM.: Contrast enhancement versus vasculature of uterine tumors. Eur. J. Radiol.4 (1984), 122.
13.
LeviC.GrayJ. E.McCulloughE. C.HatteryR. R.: The unreliability of CT numbers as absolute values. AJR139 (1982), 443.
14.
MützelW.SpeckU.: Pharmacokinetics and biotransformation of iohexol in the rat and the dog. Acta Radiol. (1980) Suppl. No. 362, p. 87.
15.
PetersonH. I.AppelgrenK. L.: Experimental studies on the uptake and retention of labelled proteins in a rat tumour. Eur. J. Cancer9 (1973), 543.
16.
RoothwellR. I.AshD. V.ThorogoodJ.: An analysis of the contribution of computed tomography to the treatment outcome in bladder cancer. Clin. Radiol.36 (1985), 369.
17.
SagerE. M.TalleK.FossåS. D.OusS.StenwigA. E.: Contrast-enhanced computed tomography to show perivesical extension in bladder carcinoma. Acta Radiol.28 (1987), 307.
18.
ShipleyW. U.ProutG. R.KaufmanS. D.PerroneT. L.: Invasive bladder cancer. The importance of initial transurethral surgery and other significant prognostic factors for improved survival with full-dose irradiation. Cancer60 (1981), 514.
19.
SlackN. H.ProutG. R.Jr: The heterogeneity of invasive bladder carcinoma and different responses to treatment. J. Urol.123 (1980), 644.
20.
SotoE. A.FriedellG. H.TiltmanA. J.: Bladder cancer as seen in giant histologic sections. Cancer39 (1977), 447.
21.
YuW. S.SagermanR. H.KingG. A.ChungC. T.YuY. W.: The value of computed tomography in the management of bladder cancer. Int. J. Radiat. Oncol. Biol. Phys.5 (1979), 135.